| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Eingereichte Version (2MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-430479
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.43047
Zusammenfassung
Chimeric antigen receptor (CAR) redirected T cells are efficacious in the treatment of leukemia/lymphoma, however, showed less capacities in eliminating solid tumors which is thought to be partly due to the lack of cytokine support in the tumor lesion. In order to deliver supportive cytokines, we took advantage of the inherent ability of mesenchymal stem cells (MSCs) to actively migrate to tumor ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags